Pregabalin 150 mg Capsule

Adult dose

This drug is administered orally in divided doses twice a day without regard to meals. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg per day, may be increased to 300 mg per day within 3 to 7 days, and may be raised to a maximum of 600 mg with 7-day intervals if necessary. - Central neuropathic pain: Starting dose of 150 mg per day, may be increased to 300 mg per day after one week.

Child dose

The safety and efficacy data are insufficient for children under 12 years of age and adolescents aged 12-17, so administration is not recommended.

This drug may increase the risk of suicidal thoughts or actions, and if there are any changes in mood or behavior during treatment, medical personnel should be informed immediately. This drug should not be used in patients with hypersensitivity to the ingredients or certain hereditary lactose intolerance. Diabetic patients should be cautious of weight gain and changes in blood sugar, and may need dose adjustments of antidiabetic medications. If symptoms of angioedema occur, the medication should be discontinued immediately. Elderly patients should be particularly cautious at the beginning of treatment due to the risk of injury from dizziness or drowsiness. Temporary visual obscurity or changes in vision may occur; consult medical personnel if any abnormal symptoms arise. Withdrawal symptoms such as insomnia, headaches, and anxiety may occur upon discontinuation, so medication adjustments should be discussed with healthcare providers. Patients with a history of drug abuse should be cautious due to the possibility of misuse of this drug. Patients with impaired renal function may require dose adjustments, and heart failure patients should use it cautiously. Co-administration with opioid analgesics may enhance central nervous system depression, so caution is advised. During early pregnancy, there is a risk of fetal malformation, so it should not be administered to pregnant women except in special cases, and women of childbearing potential should use effective contraception. Breastfeeding women should consider discontinuation of breastfeeding or the medication due to the possibility of the drug passing into breast milk. It is advisable to avoid hazardous activities like driving or operating machinery until dizziness or drowsiness resolves after taking this medication. Severe skin reactions may occur, so if there are any symptoms of skin abnormalities, the medication should be stopped immediately and medical personnel consulted. Overdose may result in drowsiness, confusion, depression, and may require treatment such as hemodialysis. This drug should be kept out of reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme drowsiness, sudden severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis, urination problems

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• elation
• decreased libido
• insomnia
• depersonalization

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. It is important to maintain a storage temperature between 15 and 30 degrees Celsius. Proper storage helps maintain the effectiveness and safety of the medication.

Appearance

A white hard capsule filled with white powder

Package unit

30 capsules/bottle, 60 capsules/bottle